{
    "2019-06-20": [
        [
            {
                "time": "2023-10-05",
                "original_text": "Drugs Under FDA Review With Blockbuster Potential",
                "features": {
                    "keywords": [
                        "Drugs",
                        "FDA",
                        "Review",
                        "Blockbuster"
                    ],
                    "sentiment_score": 0.7,
                    "policy_related": "true",
                    "investment_strategy": "false",
                    "sector_focus": [
                        "pharmaceuticals"
                    ],
                    "causal_factor": "true",
                    "causal_impact": "positive",
                    "affected_by_time_series": "false",
                    "ts_effect_direction": "none"
                }
            },
            {
                "time": "2023-10-05",
                "original_text": "From generic drugs to gummies: Boulder CBD company buys Novartis pharmaceutical plant in Broomfield for $18.8M",
                "features": {
                    "keywords": [
                        "generic drugs",
                        "CBD",
                        "Boulder",
                        "Novartis",
                        "pharmaceutical",
                        "Broomfield",
                        "$18.8M"
                    ],
                    "sentiment_score": 0.6,
                    "policy_related": "false",
                    "investment_strategy": "true",
                    "sector_focus": [
                        "pharmaceuticals",
                        "consumer goods"
                    ],
                    "causal_factor": "true",
                    "causal_impact": "positive",
                    "affected_by_time_series": "true",
                    "ts_effect_direction": "positive"
                }
            }
        ]
    ]
}